We are live on ! Find out more
BSX icon

Boston Scientific

1,512 hedge funds and large institutions have $120B invested in Boston Scientific in 2024 Q4 according to their latest regulatory filings, with 218 funds opening new positions, 617 increasing their positions, 489 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 218 | Existing positions closed: 83

26% more repeat investments, than reductions

Existing positions increased: 617 | Existing positions reduced: 489

9% more capital invested

Capital invested by funds: $111B → $120B (+$9.45B)

8% more funds holding

Funds holding: 1,3951,512 (+117)

8% more funds holding in top 10

Funds holding in top 10: 3639 (+3)

1.08% more ownership

Funds ownership: 89.89%90.98% (+1.1%)

13% less call options, than puts

Call options by funds: $797M | Put options by funds: $912M

Holders
1,512
Holders Change
+117
Holders Change %
+8.39%
% of All Funds
19.92%
Holding in Top 10
39
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+8.33%
% of All Funds
0.51%
New
218
Increased
617
Reduced
489
Closed
83
Calls
$797M
Puts
$912M
Net Calls
-$115M
Net Calls Change
+$168M
Name Holding Trade Value Shares
Change
Change in
Stake
GIBU
376
Gulf International Bank (UK)
United Kingdom
$10.2M -$113K -1,283 -1%
Acadian Asset Management
377
Acadian Asset Management
Massachusetts
$10.1M +$8.38M +95,227 +526%
M&T Bank
378
M&T Bank
New York
$10M +$524K +5,956 +6%
QCM
379
QRG Capital Management
Illinois
$9.98M +$639K +7,259 +7%
SGH
380
Sivik Global Healthcare
Connecticut
$9.82M +$440K +5,000 +5%
MGWM
381
Marks Group Wealth Management
Minnesota
$9.76M -$412K -4,676 -4%
FNT
382
First Nebraska Trust
Nebraska
$9.75M +$73.9K +840 +0.8%
SLAM
383
Swiss Life Asset Management
$9.74M +$5.36M +60,846 +126%
NIM
384
NEOS Investment Management
Connecticut
$9.71M +$1.35M +15,325 +16%
TAM
385
Thematics Asset Management
France
$9.63M +$205K +2,328 +2%
MML Investors Services
386
MML Investors Services
Massachusetts
$9.62M +$1.66M +18,840 +21%
MFG
387
Merit Financial Group
Georgia
$9.6M +$1.01M +11,502 +12%
FAT
388
First American Trust
California
$9.6M -$3.22M -36,633 -25%
HWAM
389
Hennion & Walsh Asset Management
New Jersey
$9.59M +$671K +7,618 +8%
EI
390
Ecofi Investissements
France
$9.54M -$2.42M -27,500 -19%
BCM
391
Brookstone Capital Management
Illinois
$9.46M +$1.79M +20,307 +24%
HighTower Advisors
392
HighTower Advisors
Illinois
$9.45M -$370K -4,207 -4%
Osaic Holdings
393
Osaic Holdings
Arizona
$9.3M +$514K +5,844 +5%
RBA
394
Richard Bernstein Advisors
New York
$9.18M
NWM
395
Nicola Wealth Management
British Columbia, Canada
$9.14M
VA
396
Vident Advisory
Georgia
$9.1M +$730K +8,292 +9%
KRS
397
Kentucky Retirement Systems
Kentucky
$9.04M -$123K -1,394 -1%
LP
398
LMR Partners
United Kingdom
$9.01M -$3.93M -44,594 -31%
NC
399
NBW Capital
Massachusetts
$9.01M -$202K -2,294 -2%
BCM
400
Brasada Capital Management
Texas
$8.96M -$69.2K -786 -0.8%

BSX Hedge Fund Activity: Q4 2024 in Review

1,512 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2024, worth a combined $120B — up 8.5% from $111B a quarter earlier.

Buyers outnumbered sellers: 218 funds opened new BSX positions and 83 closed out — a net gain of 135 holders — while 617 added to existing stakes and 489 trimmed.

The largest buyer was BlackRock, adding an estimated $909M. The largest seller was Massachusetts Financial Services, cutting an estimated $529M.

  • 1,512 institutional investors held Boston Scientific (BSX) as of Q4 2024, up from 1,395 in Q3 2024.
  • Funds reported $120B of Boston Scientific stock for Q4 2024, up 8.5% quarter-over-quarter.
  • 218 funds opened new Boston Scientific positions in Q4 2024 and 83 closed out, a net change of +135 holders.
  • The largest Boston Scientific buyer in Q4 2024 was BlackRock, an estimated $909M added.
  • The largest Boston Scientific seller in Q4 2024 was Massachusetts Financial Services, an estimated $529M sold.

Based on aggregated 13F filings for Q4 2024.